EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer

Lei Xia, Wenbiao Ma, Ahmad Afrashteh, Mir Amirhossein Sajadi, Hadi Fakheri, Mohammad Valilo

Biochemia medica · 15.10.2023 · 33 (3) · 266-278

DOI: 10.11613/bm.2023.030504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemia medica, online erschienen am 13.10.2023. Verfasst von Lei Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical oncology ward 2, Qinghai Provincial People's Hospital, Xining Qinghai, China. Hauptthemen laut MEDLINE: Antioxidants, Breast Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most important factors involved in the response to oxidative stress (OS) is the nuclear factor erythroid 2-related factor 2 (Nrf2), which regulates the expression of components such as antioxidative stress proteins and enzymes. Under normal conditions, Kelch-like ECH-associated protein 1 (Keap1) keeps Nrf2 in the cytoplasm, thus preventing its translocation to the nucleus and inhibiting its role. It has been established that Nrf2 has a dual function; on the one hand, it promotes angiogenesis and cancer cell metastasis while causing resistance to drugs and chemotherapy. On the other hand, Nrf2 increases expression and proliferation of glutathione to protect cells against OS. p53 is a tumour suppressor that activates the apoptosis pathway in aging and cancer cells in addition to stimulating the glutaminolysis and antioxidant pathways. Cancer cells use the antioxidant ability of p53 against OS. Therefore, in the present study, we discussed function of Nrf2 and p53 in breast cancer (BC) cells to elucidate their role in protection or destruction of cancer cells as well as their drug resistance or antioxidant properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsBreast NeoplasmsHumansFemaleKelch-Like ECH-Associated Protein 1Tumor Suppressor Protein p53NF-E2-Related Factor 2Oxidative Stress

Stichwörter der Autor:innen

Kelch-like ECH-associated protein 1 (Keap1)breast cancerdrug resistancenuclear factor erythroid 2-related factor 2 (Nrf2)p53

Substanzen

Kelch-Like ECH-Associated Protein 1AntioxidantsTumor Suppressor Protein p53NF-E2-Related Factor 2

Autor:innen und Institutionen

  • Surgical oncology ward 2, Qinghai Provincial People's Hospital, Xining Qinghai, China.
  • Department of Periodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Zitieren

APA

Xia, L., Ma, W., Afrashteh, A., Sajadi, M. A., Fakheri, H., & Valilo, M. (2023). The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer. Biochemia medica, 33(3), 266-278. https://doi.org/10.11613/bm.2023.030504

Vancouver

Xia L, Ma W, Afrashteh A, Sajadi MA, Fakheri H, Valilo M. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer. Biochemia medica. 2023;33(3):266-278. doi:10.11613/bm.2023.030504

BibTeX
@article{Xia2023,
  author = {Xia, Lei and Ma, Wenbiao and Afrashteh, Ahmad and Sajadi, Mir Amirhossein and Fakheri, Hadi and Valilo, Mohammad},
  title = {The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer},
  journal = {Biochemia medica},
  year = {2023},
  volume = {33},
  number = {3},
  pages = {266--278},
  doi = {10.11613/bm.2023.030504}
}
Kostenlos starten →